跳至主要内容
临床试验/NCT02010684
NCT02010684已完成不适用

University of California, Los Angeles (UCLA)/Drew Project EXPORT: Mood and Diabetes Empowerment & Improvement Training (MADE IT)

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
121
试验地点
2
主要终点
Change From Baseline in Hemoglobin A1c at 6 Months

研究概览

简要总结

In this project, investigators examine the impact of a mood treatment enhanced diabetes self-care intervention for depressed, low-income Latino diabetics. The investigators hypothesize that the mood treatment enhancement will lead to significant improvement in both diabetes and depression outcomes as compared with the self-care intervention alone.

详细描述

The Phase I pilot recruited older Latinos from Dr. Mangione's previous study (who agreed to participate in future research) and 10 participants from a community settings. Those with low mood and poor glycemic control were offered a 12-week intervention combining cognitive behavioral therapy mood management techniques and diabetes self-care into one seamless intervention. Drs. Mangione and Miranda supervised and reviewed (through audiotapes) well-trained health educators conducting the intervention sessions. The study manuals were modified following this Phase I pilot intervention.

The final intervention manual was tested in a randomized trial in Phase II, compared the Mood and Diabetes Empowerment and Improvement Training intervention with enhanced care as usual (providing participants with a letter regarding their mood and hemoglobin (Hb)A1c with recommendations for improving care for their provider). The target population was low-income Latinos with depression and poor glycemic control. Both mood and diabetes outcomes are evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Latino men and women age 50 and older
  • Must speak English or Spanish
  • Hb A1c greater than or equal to 8%
  • Currently not taking medication for depression
  • A score of 5 or greater on the Geriatric Depression Scale (GDS)

排除标准

  • Persons who are legally blind, dialysis dependent, diagnosed with dementia, and/or with hemiparesis from a cerebral vascular accident
  • Do not have sufficient hearing or cognitive function

结局指标

主要结局

Change From Baseline in Hemoglobin A1c at 6 Months

时间窗: Baseline and 6 months

Hemoglobin A1c (HbA1c) measures glycemic control over the past three months. HbA1c was measured by a blood draw and laboratory test.

Change From Baseline in Depression Measures at 6 Months

时间窗: Baseline and 6 months

The Geriatric Depression Scale (GDS) measures depression in older adults. The short form we used consists of 15 yes or no questions. The scale range is 0 to 15, where higher scores indicate greater severity of depression. The Patient Health Questionnaire-9 (PHQ-9) measures depression in patients. The questionnaire consists of 9 questions where patients self report how frequently they have depression symptoms over the past two weeks. The scale ranges is 0 to 27 where higher scores indicate greater severity of depression.

次要结局

  • Change From Baseline in Blood Pressure at 6 Months(Baseline and 6 months)
  • Change From Baseline in Low Density Lipoprotein-C at 6 Months(Baseline and 6 months)
  • Change From Baseline in EQ-5D at 6 Months(Baseline and 6 months)
  • Change From Baseline in Self-Efficacy (Diabetes Empowerment Scale) at 6 Months(Baseline and 6 months)
  • Change From Baseline in Yale Physical Activity Scale - Index Summary Score at 6 Months(Baseline and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Jeanne Miranda

Jeanne Miranda Ph.D.

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验